Planet 13 Holdings Inc
CNSX:PLTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing E-hualu Information Technology Co Ltd
SZSE:300212
|
CN |
|
Deutsche EuroShop AG
XETRA:DEQ
|
DE |
|
Tangrenshen Group Co Ltd
SZSE:002567
|
CN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (10.1), the stock would be worth CA$-0.86 (508% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -2.5 | CA$0.21 |
0%
|
| Industry Average | 10.1 | CA$-0.86 |
-508%
|
| Country Average | 14.4 | CA$-1.22 |
-681%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
CA$62.7m
|
/ |
Jan 2026
$-18m
|
= |
|
|
CA$62.7m
|
/ |
Dec 2026
$-561k
|
= |
|
|
CA$62.7m
|
/ |
Dec 2027
$8.8m
|
= |
|
|
CA$62.7m
|
/ |
Dec 2028
$13.2m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
P
|
Planet 13 Holdings Inc
CNSX:PLTH
|
68.4m CAD | -2.5 | -0.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869.1B USD | 28.5 | 42.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
555.5B USD | 16.9 | 26.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 11.7 | 19.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.9B GBP | 16.6 | 30 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
289.8B USD | 9.9 | 15.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228B CHF | 12.5 | 20.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 386.8 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 8.2 | 11.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.5B USD | 7.7 | 20.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119B USD | 7.1 | 16.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
Planet 13 Holdings Inc
Glance View
Planet 13 Holdings, Inc. engages in the manufacture and production of cannabis products. The company is headquartered in Las Vegas, Nevada and currently employs 575 full-time employees. The company went IPO on 2018-06-21. The firm owns and manufactures cannabis products under various brands, including HaHa (gummies and beverages), Dreamland (chocolates), Trendi (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes). Through its subsidiaries in Nevada, it holds six licenses for cultivation (three medical licenses and three recreational licenses), six licenses for production (three medical licenses and three recreational licenses), three dispensary licenses (one medical license and two recreational licenses) and two distribution licenses (one active and one conditional). The company operates two dispensaries in Nevada under two adult-use and one medical licenses. Its manufactured products and Trendi-branded third-party flower are distributed through Nevada under its Nevada distribution license. The firm sells over 123 different strains of cannabis.
